Apimeds Pharmaceuticals U... (APUS)
NYSE: APUS
· Real-Time Price · USD
1.83
0.05 (2.81%)
At close: Jun 20, 2025, 3:39 PM
1.75
-4.30%
After-hours: Jun 20, 2025, 06:06 PM EDT
Apimeds Pharmaceuticals US Inc Revenue
Apimeds Pharmaceuticals US Inc reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2024, Apimeds Pharmaceuticals US Inc generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
2
Market Cap
21.17M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|